Compliance with ICH E6(R3) Guidelines Using SIP

This document is a technical report that outlines the ICH E6(R3) guideline, which introduces a modular structure for clinical trials, emphasizing innovative trial designs, data integrity, and participant safety. It details how the Cognizant Shared Investigator Platform (SIP) supports compliance with these guidelines by facilitating decentralized clinical trial elements and enhancing collaboration between sponsors and research sites. The report explains the importance of maintaining essential records, ensuring data integrity, and implementing a Quality by Design (QbD) approach. It describes how SIP enables real-time data sharing, remote monitoring, and centralized access to study protocols, thereby improving site preparedness and regulatory compliance. The document also highlights SIP's role in ensuring inspection readiness and enhancing participant safety through robust access controls and streamlined operations. Overall, the report emphasizes the strategic importance of SIP in modernizing clinical trial conduct in alignment with ICH E6(R3) principles.